Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Saxenda also is endorsed for pediatric patients ages 12 through 17 who are obese and weigh at least 60 kg (132 pounds)
The medication is typically prescribed for adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m with weight-related comorbidities
Ready to find out if semaglutide is right for you
Benefits include reduced appetite, consistent weight loss, improved insulin sensitivity, and better control over metabolic health markers
Fasenra was first approved in 2017 to treat severe eosinophilic asthma
US$ 23.83
US$ 20.26
US$ 20.26
US$ 24.83
US$ 20.25
